Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.57 +0.31 (+0.79%)
At close: Oct 1, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Cash from Operations (2019 - 2026)

Updated

Harmony Biosciences Holdings' Cash from Operations was $92.43 million in Q2 2026, up 16.5% from $79.33 million a year earlier and up 233.0% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Cash from Operations (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Harmony Biosciences Holdings' Cash from Operations was $355.08 million through Jun 30, 2026, up 36.9% year-over-year; for FY2025, it was $348.2 million, up 58.4% from FY2024.

  • Cash from Operations has now increased for four consecutive years.
  • In earlier years, Cash from Operations was $219.82 million in FY2024 (+0.2%), $219.39 million in FY2023 (+51.9%), $144.47 million in FY2022 (+46.6%) and $98.56 million in FY2021.
  • Quarterly Cash from Operations has moved between $26.68 million (Q4 2022) and $126.15 million (Q4 2025) over five years.
  • Compared with a year earlier, Cash from Operations was higher in six of the last eight quarters, with growth averaging 28.1%.
  • The best year-over-year quarter for Cash from Operations over five years was Q4 2021 (growth of 273.6%); the worst was Q4 2022 (a decline of 28.9%).
  • Per Business Quant data, HRMY's Cash from Operations in the three quarters before Q2 2026 was $27.76 million (Q1 2026), $126.15 million (Q4 2025) and $108.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Harmony Biosciences Holdings 2.28 Bn -474.81 Mn 198.08 Mn 92.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92.43 Mn
Mar 31, 2026 27.76 Mn
Dec 31, 2025 126.15 Mn
Sep 30, 2025 108.73 Mn
Jun 30, 2025 79.33 Mn
Mar 31, 2025 33.99 Mn
Dec 31, 2024 75.56 Mn
Sep 30, 2024 70.50 Mn
Jun 30, 2024 42.62 Mn
Mar 31, 2024 31.14 Mn
Dec 31, 2023 76.67 Mn
Sep 30, 2023 63.10 Mn
Jun 30, 2023 37.06 Mn
Mar 31, 2023 42.56 Mn
Dec 31, 2022 26.68 Mn
Sep 30, 2022 55.21 Mn
Jun 30, 2022 33.73 Mn
Mar 31, 2022 28.85 Mn
Dec 31, 2021 37.53 Mn
Sep 30, 2021 30.42 Mn
API Access

Harmony Biosciences Holdings Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=HRMY&period=max&api_key=YOUR_API_KEY